Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses.

Gubareva LV, Fry AM.

J Infect Dis. 2010 Mar;201(5):656-8. doi: 10.1086/650465. No abstract available.

PMID:
20100087
[PubMed - indexed for MEDLINE]
Free Article
2.

Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.

[No authors listed]

Wkly Epidemiol Rec. 2007 Apr 27;82(17):149-50. English, French. No abstract available.

PMID:
17465078
[PubMed - indexed for MEDLINE]
Free Article
3.

Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.

Govorkova EA, Marathe BM, Prevost A, Rehg JE, Webster RG.

Antiviral Res. 2011 Aug;91(2):81-8. doi: 10.1016/j.antiviral.2011.05.008. Epub 2011 May 27.

PMID:
21635924
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA.

Antiviral Res. 2002 Aug;55(2):307-17.

PMID:
12103431
[PubMed - indexed for MEDLINE]
5.

Editorial commentary: viral susceptibility and the choice of influenza antivirals.

Monto AS.

Clin Infect Dis. 2008 Aug 1;47(3):346-8. doi: 10.1086/589749. No abstract available.

PMID:
18582205
[PubMed - indexed for MEDLINE]
Free Article
6.

Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.

Lackenby A, Democratis J, Siqueira MM, Zambon MC.

Antivir Ther. 2008;13(6):809-20.

PMID:
18839782
[PubMed - indexed for MEDLINE]
7.

Drug resistance. A 'wimpy' flu strain mysteriously turns scary.

Enserink M.

Science. 2009 Feb 27;323(5918):1162-3. doi: 10.1126/science.323.5918.1162. No abstract available.

PMID:
19251605
[PubMed - indexed for MEDLINE]
8.

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto AS.

J Infect Dis. 2004 Nov 1;190(9):1627-30. Epub 2004 Sep 28.

PMID:
15478068
[PubMed - indexed for MEDLINE]
Free Article
9.

Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.

Lin X, Zhou J, Zhang Y, Wu J, Zhang F, Li Z, Zhang Y, Bi S, Shu Y, Wang Y.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1305-8. doi: 10.1016/j.bbrc.2009.10.142. Epub 2009 Oct 29.

PMID:
19879239
[PubMed - indexed for MEDLINE]
10.

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.

Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, Payungporn S, Poovorawan Y, Hannongbua S.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):390-4. doi: 10.1016/j.bbrc.2009.05.066. Epub 2009 May 20.

PMID:
19463784
[PubMed - indexed for MEDLINE]
11.

Implications of antiviral resistance of influenza viruses.

Monto AS.

Clin Infect Dis. 2009 Feb 15;48(4):397-9. doi: 10.1086/596312. No abstract available.

PMID:
19586376
[PubMed - indexed for MEDLINE]
Free Article
12.

A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.

Duwe S, Schweiger B.

J Virol Methods. 2008 Nov;153(2):134-41. doi: 10.1016/j.jviromet.2008.07.017. Epub 2008 Sep 19.

PMID:
18725246
[PubMed - indexed for MEDLINE]
13.

Neuraminidase inhibitor resistance in influenza viruses.

Reece PA.

J Med Virol. 2007 Oct;79(10):1577-86. Review.

PMID:
17705169
[PubMed - indexed for MEDLINE]
14.

[In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses].

Kubo S, Kakuta M, Yamashita M.

Jpn J Antibiot. 2010 Oct;63(5):337-46. Japanese.

PMID:
21268406
[PubMed - indexed for MEDLINE]
15.

Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.

Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.

Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.

PMID:
19523442
[PubMed - indexed for MEDLINE]
16.

Developing new antiviral agents for influenza treatment: what does the future hold?

Hayden F.

Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13. doi: 10.1086/591851. Review.

PMID:
19067613
[PubMed - indexed for MEDLINE]
Free Article
17.

Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1).

Uyeki T.

N Engl J Med. 2009 Dec 3;361(23):e110. doi: 10.1056/NEJMopv0910738. Epub 2009 Nov 18. No abstract available.

PMID:
19923564
[PubMed - indexed for MEDLINE]
Free Article
18.

Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.

Smee DF, Sidwell RW, Morrison AC, Bailey KW, Baum EZ, Ly L, Wagaman PC.

Antiviral Res. 2001 Dec;52(3):251-9.

PMID:
11675142
[PubMed - indexed for MEDLINE]
19.

Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.

Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, Yamashita M.

Antimicrob Agents Chemother. 2010 Mar;54(3):1256-64. doi: 10.1128/AAC.01311-09. Epub 2010 Jan 4.

PMID:
20047917
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.

Tian L, Wang Z, Wu H, Wang S, Wang Y, Wang Y, Xu J, Wang L, Qi F, Fang M, Yu D, Fang X.

J Ethnopharmacol. 2011 Sep 1;137(1):534-42. doi: 10.1016/j.jep.2011.06.002. Epub 2011 Jun 12.

PMID:
21699971
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk